Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-12-2022 | Hyperparathyroidism | Case report

Amiloride

Hypercalcaemia and unmasking of hyperparathyroidism: case report

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Golbus A, et al. Ogilvie Syndrome: Treatment of Hypokalemia With Amiloride Unmasked Hypercalcemia and Hyperparathyroidism. Journal of the American Society of Nephrology 33: 747 (plus poster) abstr. SA-PO517, 2022. Available from: URL: https://jasn.asnjournals.org/ [abstract] Golbus A, et al. Ogilvie Syndrome: Treatment of Hypokalemia With Amiloride Unmasked Hypercalcemia and Hyperparathyroidism. Journal of the American Society of Nephrology 33: 747 (plus poster) abstr. SA-PO517, 2022. Available from: URL: https://​jasn.​asnjournals.​org/​ [abstract]
Metadata
Title
Amiloride
Hypercalcaemia and unmasking of hyperparathyroidism: case report
Publication date
01-12-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-29222-2

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Metformin